NIH-funded research NIH-funded research

Identifying molecular types of Alzheimer's disease linked to cognitive function

Official title: Identification and characterization of molecular subtypes of Alzheimer's disease associated with cognitive function through cross-omics data integration

Funded at Washington University · NIH-11117069 · Data updated 2026-11-12

This study is looking at different types of Alzheimer's disease to see how they affect thinking skills in older adults, with the hope of finding new ways to diagnose and treat the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 15, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$148,581
NIH project number5K25AG083057-03
Project IDNIH-11117069 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 65 and older who are experiencing cognitive decline or have been diagnosed with Alzheimer's disease.

Less likely to help

Patients under the age of 65 or those without cognitive impairment may not benefit from this research.

What this research studies

This research focuses on understanding different molecular subtypes of Alzheimer's disease (AD) and how they relate to cognitive function in older adults. The project involves integrating various biological data types, known as cross-omics, to identify specific biomarkers that could help in diagnosing and treating AD. The principal investigator, Dr. Eteleeb, will receive training in neurology and genetics to enhance his ability to conduct this important research. The ultimate goal is to improve our understanding of AD and develop targeted interventions for patients.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment options for patients with Alzheimer's disease.

How similar studies have gone: Previous research has shown promise in identifying molecular subtypes of Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Eteleeb, Abdallah M — Washington University
  • Study coordinator: Eteleeb, Abdallah M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.